Thought Leader Select Seeking New Sales Executive in U.S. Market

February 8, 2012 · Leave a comment

Thought Leader Select is looking for a dynamic, talented individual to fill its newest U.S. Sales Executive position.

Founded in 2006, Thought Leader Select is a firm that serves the biopharmaceutical industry by providing strategic counsel on the best ways to work with medical experts (known as “thought leaders” and “key opinion leaders”) and assessing experts within a host of therapeutic areas such as diabetes, oncology, and neurology.

Interested applicants should go to the company’s human resources site for more information on this exciting opportunity.

TAGS:                   

Beyond the Specialist: The Growing Importance of Thought Leadership in Primary Care, Allied Health Professions

January 12, 2012 · Leave a comment

By Brian Castle and Kristen Smithwick

When most people think about thought leaders in medicine, specialists in oncology, neurology, rheumatology and other therapeutic areas immediately come to mind.  However, with the proliferation of illnesses and conditions ranging from diabetes and obesity to asthma, gastrointestinal diseases and psychiatric disorders, key opinion leaders in primary care and allied health professions are more important than ever.

In addition to the growing incidence of several “lifestyle” conditions, the structure of U.S. healthcare dictates that people suffering in these areas see their primary care physicians (PCPs), nurses, nurse practitioners, physician assistants, and pharmacists with much greater frequency than their specialists.  As a result, more PCPs and allied health professionals are joining their specialist colleagues in all of the critical areas that define thought leadership, including publishing, basic and clinical research, clinical practice, speaking, and advocacy involvement.

Thought Leader Select has conducted multiple assessments of thought leader populations in a variety of therapeutic areas, with particular attention to the impact of PCPs, also known as general practitioners, in areas of treatment as diverse as diabetes, allergies, infectious disease, and gastrointestinal conditions.  Primary care physicians, along with their nurse practitioner (NP), physician assistant (PA), and registered nurse colleagues, consistently distinguish themselves in many of the traditional areas of thought leadership once assumed to be the domain of specialists and sub-specialists.

Leaders ... read more »

TAGS:                                                                                             

Thought Leader Select Announces New KOL Identification and Profiling Projects in Oncology, Neurology

December 2, 2011 · Leave a comment

Thought Leader Select is pleased to announce a series of key opinion leader (KOL) identification and profiling projects to support multiple therapeutic areas for a top five global biopharmaceutical company.

In these research assessments, Thought Leader Select will identify and profile leading medical experts in neurology and oncology to support drug development initiatives in various cancers and neurological disorders. The oncologists and neurologists will represent many of the leading physicians at top medical centers of excellence throughout Canada.

Thought Leader Select will use its validated, objective deep profiling methodology to assess the skills and experience of the thought leaders in oncology and neurology in multiple research categories, including their areas of expertise, medical/scientific journal publishing history, and participation in basic and clinical research.  The company’s research group is comprised of subject-matter experts in medicine, with decades of experience working in medical research and clinical settings in the United States, Canada, Australia, and Africa.

The project will yield over 100 physicians who may advise the company on its development efforts in the treatment of cancers and neurological diseases. Typically, key opinion leaders serve on scientific advisory boards and participate in late-stage clinical trials to monitor the effectiveness of new drugs in larger patient populations.

“We are honored that this company has chosen to partner with us again to use effective solutions to identify ... read more »

TAGS:                                                         

Thought Leader Select announces 50 Percent Annual Growth for 2010

February 3, 2011 · Leave a comment

New press release out today from the offices of Thought Leader Select:

Thought Leader Select announces 50 Percent Annual Growth for 2010

FOR IMMEDIATE RELEASE

February 3, 2010 (CHAPEL HILL, NC)-Thought Leader Select, a Research Triangle, NC-based research and consulting company serving the biopharmaceutical and healthcare industries, announces 50 percent year-over-year growth for 2010.

Founded in 2006, Thought Leader Select is a specialty firm dedicated to strengthening industry collaborations with medical experts for the development of next generation medicines. The company’s practice area focuses on three aspects of working with key opinion leaders (KOLs) in the medical community:  identification and profiling, mapping, and engagement.

During the 2010 fiscal year, the company grew its revenues by 50 percent over fiscal year 2009, according to Kristen Smithwick, Vice President of Business Development, Marketing, and Strategic Planning.  “We had a very strong year in 2010, and we have solidified our position as one of the preeminent thought leader engagement companies in the marketplace,” stated Smithwick.

The company marked 2010 by generating a record 28 customized research assessments for 10 of the top 50 global biopharmaceutical companies (measured by revenue).  Thought Leader Select identified and profiled over 2500 KOLs in 30 countries. The medical experts represented multiple therapeutic areas and disease states, including neurology, ophthalmology, cardiology, endocrinology, and immunology.

Thought Leader Select used its industry-leading “deep profiling” methodology to ... read more »

TAGS:                                                     

Fast Facts from Thought Leader Select—How Much Does a KOL Publish?

May 20, 2010 · Leave a comment

Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their appropriate advice and guidance in the development of new medicines.

Thought Leader Select measures many areas where KOLs leave their respective marks in the medical community, including conducting clinical research studies, publishing articles in leading journals, and presenting breakthrough knowledge at scientific conferences.

In a recent assessment of over 200 specialists in epilepsy, Thought Leader Select measured the publishing frequency of these global key opinion leaders. Using keywords to link leading neurologists with new research knowledge in epilepsy, Thought Leader Select found most KOLs had published between 10 and 30 articles on epilepsy since 2004. The most prolific thought leader tallied 170 published articles in the last six years, amounting to more than 28 manuscripts a year. The top quartile published between 40 and 100 scientific articles within the last six years. The top KOL neurologists are undoubtedly very busy advancing the science of epilepsy, from understanding its etiology to treating the condition.

TAGS:                               

Thought Leader Select announces neurology key opinion leader work for top-20 global pharmaceutical company

March 17, 2010 · Leave a comment

New press release out today from the offices of Thought Leader Select!

FOR IMMEDIATE RELEASE

March 9, 2010 (CHAPEL HILL, NC) —Thought Leader Select, a company dedicated to delivering solutions for better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, is proud to announce the commencement of a new project for a top-20 global pharmaceutical company.

Deep profiling has proven to be up to three times more effective than other more traditional methods, such as influence mapping, in matching pharmaceutical companies with the key opinion leaders who exhibit the skills and experiences needed to develop tomorrow’s drug therapies (source: Thought Leader Select internal comparative research).

Upon project delivery, the client company will be able to utilize Thought Leader Select’s customized engagement recommendations, research reporting and a web-based profiling tool to develop world-class clinical investigation teams and high-synergy advisory boards. As the client builds its investigative teams and advisory boards, the skills and experiences of the global KOLs will drive key applications.

In addition to Thought Leader Select’s deep profiling, the firm will provide qualitative research of the key opinion leaders selected by the pharmaceutical company to aid in the development of their neurology product.  This study will assess KOL preferences for treating certain neurological symptoms, in ... read more »

TAGS: